Category: Companies

Companies

Symbotic Inc (SYM) Shares Soar Above 1-Year High

The stock of Symbotic Inc (NASDAQ: SYM) has increased by 4.74 when compared to last closing price of 29.52.Despite this, the company has seen a

Companies

Intra-Cellular Therapies Inc (ITCI) Stock Experiences 18.88% Monthly Change

In the past week, ITCI stock has gone up by 15.12%, with a monthly gain of 18.88% and a quarterly surge of 9.32%. The volatility

Companies

Neurocrine Biosciences, Inc. (NBIX) Stock: What the Analysts are Saying

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has a price-to-earnings ratio that is above its average at 37.69x. The stock has a 36-month beta value of 0.36.

Companies

ASML Holding NV (ASML) Shares Decline Despite Market Challenges

The stock price of ASML Holding NV (NASDAQ: ASML) has dropped by -3.03 compared to previous close of 715.14. Despite this, the company has seen

Companies

Wingstop Inc (WING) Stock: Tracking the Weekly Performance

The stock of Wingstop Inc (WING) has seen a -17.50% decrease in the past week, with a -28.14% drop in the past month, and a

Companies

Unisys Corp. (UIS): A Technical Analysis

UIS has 36-month beta value of 0.76. Analysts have mixed views on the stock, with 2 analysts rating it as a “buy,” 1 as “overweight,”

Companies

AnaptysBio Inc (ANAB) Shares Down Despite Recent Market Volatility

AnaptysBio Inc (NASDAQ: ANAB)’s stock price has gone decline by -30.42 in comparison to its previous close of 30.80, however, the company has experienced a

Companies

The Impact of Market Fluctuations on Nuvation Bio Inc’s (NUVB) Stock

The stock of Nuvation Bio Inc (NUVB) has gone up by 6.44% for the week, with a 7.83% rise in the past month and a

Companies

Analyzing the Price-to-Earnings Ratio of Tharimmune Inc (THAR)

The 36-month beta value for THAR is also noteworthy at 1.51. There are mixed opinions on the stock, with 0 analysts rating it as a

Companies

Twilio Inc (TWLO) Stock: A SWOT Analysis

Company’s 36-month beta value is 1.36.Analysts have differing opinions on the stock, with 6 analysts rating it as a “buy,” 4 as “overweight,” 3 as